Group One Trading’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-49,400
Closed -$1.64M 8323
2022
Q4
$1.64M Buy
49,400
+4,900
+11% +$158K ﹤0.01% 1997
2022
Q3
$1.4M Sell
44,500
-9,900
-18% -$321K ﹤0.01% 2225
2022
Q2
$1.66M Buy
54,400
+26,600
+96% +$719K ﹤0.01% 2227
2022
Q1
$722K Buy
27,800
+27,400
+6,850% +$652K ﹤0.01% 3427
2021
Q4
$8K Sell
400
-27,800
-99% -$533K ﹤0.01% 7489
2021
Q3
$543K Sell
28,200
-6,200
-18% -$124K ﹤0.01% 4104
2021
Q2
$763K Buy
34,400
+26,900
+359% +$571K ﹤0.01% 3725
2021
Q1
$197K Buy
7,500
+400
+6% +$9.51K ﹤0.01% 5047
2020
Q4
$133K Buy
7,100
+4,100
+137% +$76.6K ﹤0.01% 4358
2020
Q3
$51K Sell
3,000
-33,600
-92% -$653K ﹤0.01% 4636
2020
Q2
$852K Buy
36,600
+20,100
+122% +$291K ﹤0.01% 2183
2020
Q1
$139K Buy
+16,500
New +$139K ﹤0.01% 3038
2019
Q1
Sell
-2,600
Closed -$17K 5546
2018
Q4
$17K Buy
2,600
+2,300
+767% +$39.2K ﹤0.01% 4096
2018
Q3
$4K Buy
+300
New +$4.65K ﹤0.01% 4923
2017
Q4
Sell
-1,500
Closed -$21K 5369
2017
Q3
$21K Buy
1,500
+1,000
+200% +$14.3K ﹤0.01% 4052
2017
Q2
$8K Sell
500
-200
-29% -$2.88K ﹤0.01% 4300
2017
Q1
$10K Buy
+700
New +$9.79K ﹤0.01% 4126
2016
Q4
Sell
-12,000
Closed -$231K 4958
2016
Q3
$231K Sell
12,000
-5,300
-31% -$104K ﹤0.01% 2368
2016
Q2
$337K Sell
17,300
-1,000
-5% -$19.6K ﹤0.01% 2022
2016
Q1
$377K Sell
18,300
-12,400
-40% -$244K 0.01% 1886
2015
Q4
$630K Buy
30,700
+17,600
+134% +$337K 0.01% 1629
2015
Q3
$224K Buy
13,100
+8,800
+205% +$161K ﹤0.01% 2424
2015
Q2
$80K Hold
4,300
﹤0.01% 3231
2015
Q1
$82K Buy
+4,300
New +$79.5K ﹤0.01% 3026

Other funds holding VIVO

Group One Trading's VIVO Position: Q3 2021 in Review

Group One Trading sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 6,180 shares — an estimated $123K sold.

Group One Trading first reported a position in VIVO in Q3 2014 and held it in 13 quarters. The position peaked at $1.04M in Q3 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • Group One Trading reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • Group One Trading sold 6,180 Meridian Bioscience Inc shares in Q3 2021, an estimated $123K.
  • Group One Trading first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 13 quarters.
  • Group One Trading's Meridian Bioscience Inc position peaked at $1.04M in Q3 2020.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.